tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (AU:CUV)
:CUV
Australian Market

Clinuvel Pharmaceuticals (CUV) Ratios

Compare
70 Followers

Clinuvel Pharmaceuticals Ratios

AU:CUV's free cash flow for Q2 2025 was AU$0.91. For the 2025 fiscal year, AU:CUV's free cash flow was decreased by AU$ and operating cash flow was AU$0.46. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
17.37 7.44 10.24 11.81 9.10
Quick Ratio
16.65 7.06 10.10 11.45 8.94
Cash Ratio
1.28 0.94 2.00 4.27 3.10
Solvency Ratio
2.09 1.05 1.12 2.60 1.80
Operating Cash Flow Ratio
1.82 1.45 2.90 2.21 1.72
Short-Term Operating Cash Flow Coverage
0.00 -2.29 -5.48 0.00 0.00
Net Current Asset Value
AU$ 208.66MAU$ 159.72MAU$ 121.33MAU$ 93.02MAU$ 65.68M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 0.02
Debt-to-Equity Ratio
<0.01 <0.01 0.01 0.01 0.02
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.18 1.15 1.10 1.13
Debt Service Coverage Ratio
0.00 -2.43 -4.32 15.81 598.68
Interest Coverage Ratio
0.00 12.81 14.55 16.50 393.90
Debt to Market Cap
0.00 -0.02 >-0.01 0.00 0.00
Interest Debt Per Share
0.01 0.08 0.07 0.06 0.03
Net Debt to EBITDA
-0.31 -0.49 -0.75 -1.35 -2.03
Profitability Margins
Gross Profit Margin
90.83%64.59%70.93%73.38%56.60%
EBIT Margin
55.97%62.27%55.68%56.97%35.44%
EBITDA Margin
56.83%59.20%53.37%55.39%36.81%
Operating Profit Margin
53.94%52.23%50.34%55.65%31.31%
Pretax Profit Margin
63.51%58.19%52.22%53.60%35.44%
Net Profit Margin
42.60%39.08%31.77%51.54%51.12%
Continuous Operations Profit Margin
42.60%39.08%31.77%51.54%46.22%
Net Income Per EBT
67.08%67.15%60.83%96.17%144.24%
EBT Per EBIT
117.73%111.41%103.74%96.32%113.18%
Return on Assets (ROA)
16.42%15.73%14.42%22.78%20.42%
Return on Equity (ROE)
18.45%18.59%16.63%25.04%23.10%
Return on Capital Employed (ROCE)
22.01%24.20%25.24%26.73%13.91%
Return on Invested Capital (ROIC)
14.74%17.93%16.21%25.64%18.09%
Return on Tangible Assets
16.43%15.76%14.45%22.85%20.51%
Earnings Yield
6.81%3.46%2.85%1.63%1.32%
Efficiency Ratios
Receivables Turnover
5.59 3.53 4.06 2.98 4.92
Payables Turnover
1.48 9.93 73.71 5.50 9.89
Inventory Turnover
0.89 2.91 10.43 4.01 10.97
Fixed Asset Turnover
12.81 27.47 24.34 18.43 13.63
Asset Turnover
0.39 0.40 0.45 0.44 0.40
Working Capital Turnover Ratio
0.44 0.54 0.59 0.60 0.53
Cash Conversion Cycle
229.59 192.08 120.03 147.07 70.45
Days of Sales Outstanding
65.30 103.53 89.98 122.40 74.12
Days of Inventory Outstanding
411.25 125.29 35.00 91.08 33.26
Days of Payables Outstanding
246.96 36.74 4.95 66.41 36.92
Operating Cycle
476.56 228.82 124.98 213.48 107.37
Cash Flow Ratios
Operating Cash Flow Per Share
0.47 0.75 0.81 0.39 0.29
Free Cash Flow Per Share
0.47 0.73 0.80 0.37 0.27
CapEx Per Share
<0.01 0.02 <0.01 0.02 0.02
Free Cash Flow to Operating Cash Flow
0.99 0.97 0.99 0.96 0.94
Dividend Paid and CapEx Coverage Ratio
8.40 12.29 23.88 9.22 6.72
Capital Expenditure Coverage Ratio
71.65 35.92 91.78 22.55 15.96
Operating Cash Flow Coverage Ratio
33.31 36.92 31.73 14.78 10.75
Operating Cash Flow to Sales Ratio
0.26 0.47 0.61 0.40 0.44
Free Cash Flow Yield
4.14%4.06%5.37%1.21%1.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.68 28.87 35.14 61.34 75.90
Price-to-Sales (P/S) Ratio
6.23 11.28 11.16 31.62 38.80
Price-to-Book (P/B) Ratio
2.62 5.37 5.84 15.36 17.53
Price-to-Free Cash Flow (P/FCF) Ratio
24.15 24.62 18.61 82.41 95.00
Price-to-Operating Cash Flow Ratio
23.88 23.93 18.40 78.75 89.05
Price-to-Earnings Growth (PEG) Ratio
1.74 0.61 -2.20 1.00 -4.12
Price-to-Fair Value
2.62 5.37 5.84 15.36 17.53
Enterprise Value Multiple
10.66 18.56 20.17 55.73 103.38
Enterprise Value
EV to EBITDA
10.66 18.56 20.17 55.73 103.38
EV to Sales
6.06 10.99 10.77 30.87 38.05
EV to Free Cash Flow
23.47 23.98 17.94 80.46 93.18
EV to Operating Cash Flow
23.14 23.31 17.75 76.89 87.34
Tangible Book Value Per Share
4.32 3.32 2.53 1.99 1.46
Shareholders’ Equity Per Share
4.32 3.33 2.54 2.00 1.46
Tax and Other Ratios
Effective Tax Rate
0.33 0.33 0.39 0.04 -0.30
Revenue Per Share
1.81 1.59 1.33 0.97 0.66
Net Income Per Share
0.77 0.62 0.42 0.50 0.34
Tax Burden
0.67 0.67 0.61 0.96 1.44
Interest Burden
1.13 0.93 0.94 0.94 1.00
Research & Development to Revenue
0.05 0.02 0.02 0.01 0.01
SG&A to Revenue
0.02 0.02 0.02 0.02 0.04
Stock-Based Compensation to Revenue
0.02 0.11 0.09 0.05 0.05
Income Quality
0.61 1.21 1.91 0.78 0.94
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis